MedPath

Ayurvedic treatment for pai

Not Applicable
Conditions
Health Condition 1: null- ï?µEighty (80) patients with MSD, meeting all inclusion/exclusion criteria will be included in the study
Registration Number
CTRI/2017/09/009907
Lead Sponsor
MB Life Scienes Pvt Ltd New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with musculoskeletal pain and swelling, fulfilling the diagnostic criteria of MS, willing to give consent for participating in the study. Patients who are currently on analgesics/NSAID, will be given a washout period of 7days prior to recruitment

Exclusion Criteria

Patients having severe MSD, those who are suffering from dermatitis or had a history of dermatitis, pregnant and lactating women, any other conditions which in the opinion of investigator will places the subject at risk or will influence the conduct of study or interpretation of results

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Before and after the treatment period of 7 days <br/ ><br>Changes in following parameters between day 1 and day 7: <br/ ><br>â?¢Subjective parameters: Pain (VAS), Tenderness, Shotha (swelling/Inflammation), Stabdata (Stiffness), Physician Global Assessment <br/ ><br>â?¢Objective parameters: Range of Motion (Goniometer) <br/ ><br> At screening: RA, CRP, Serum Uric acid <br/ ><br> Safety Parameters: CBC, LFT, RFT (base line and 7th day) (Only 50% of Patients) <br/ ><br>Timepoint: Day 0, 8, 22,37
Secondary Outcome Measures
NameTimeMethod
Assessment of subsidence after treatment period during the follow-up period up to 30 days. <br/ ><br>Subjective parameters will be assessed on day 15th and 30th day <br/ ><br>Timepoint: Day0, 8, 22 and 37
© Copyright 2025. All Rights Reserved by MedPath